Is the Indian clinical trials segment pick up a mirage?
This article was originally published in Scrip
Executive Summary
India has approved more than 130 clinical trials so far this year, surpassing the number of studies cleared in all of 2013, but industry appears divided on whether the pick-up signals real gains in the beleaguered segment.